- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06834906
Usability User Testing of the Easy-EyeFM AI Platform
Easy-EyeFM is a code-free artificial intelligence platform designed for ophthalmologists to provide diagnostic and treatment recommendations and help doctors develop customized diagnostic models.
This project aims to evaluate the usability and user-friendliness of the Easy-EyeFM platform for physicians. The study will gather feedback from medical professionals to evaluate the intuitiveness and effectiveness of the platform in supporting model customization and medical image analysis tasks.
Subjects will participate in the trial of the Easy-EyeFM platform and the comparison with the existing commercial platform (AutoML) at the appointed time. The researchers will inform subjects of relevant precautions and assist them to read the user manual before the test. Subjects will complete model customization and picture diagnosis within the prescribed test time, and according to the test results, Score the human-computer interaction experience of the AI platform, fill in the questionnaire, and finally complete the evaluation content.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jinyuan Wang
- Phone Number: 086-15801191316
- Email: jinyuanwang@tsinghua.edu.cn
Study Contact Backup
- Name: Hongqiu Wang
- Email: hwang007@connect.hkust-gz.edu.cn
Study Locations
-
-
-
Beijing, China
- Recruiting
- Tsinghua University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Medical students or doctors
- Have enough time to participate in this program, about 1 hour continuous assessment
- Agree to sign the informed consent form
Exclusion Criteria:
- Poor computer and mobile phone use and reading ability
- Poor language expression or dialect category is not included in the speech recognition function of the platform
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: group A
|
AI platforms using
|
|
Experimental: group B
|
AI-platform using
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
System Usability Scale
Time Frame: 1 day
|
Minimum Value: 0 Maximum Value: 100 Higher scores indicate a better outcome, meaning higher system usability.
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Usage Time
Time Frame: 1 day
|
1 day
|
|
Users Assistance Requests Times
Time Frame: 1 day
|
1 day
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Tien Yin Wong, Tsinghua University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Easy-EyeFM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ocular Diseases
-
Kazakh Eye Research InstituteActive, not recruitingRhegmatogenous Retinal Detachment | Hypotony OcularKazakhstan
-
National Taiwan University HospitalUnknownGlaucoma; Ocular Disorders (I.E. Caused by Ocular Disorders)Taiwan
-
Shiraz University of Medical SciencesCompletedIncreased Intra Ocular Pressure (IOP)Iran, Islamic Republic of
-
Laboratorios Sophia S.A de C.V.CompletedTolerability | Safety | Ocular Surface | Ocular ComfortMexico
-
CHA UniversityHanlim Pharm. Co., Ltd.CompletedGlaucoma | Ocular HypertensiveKorea, Republic of
-
Laboratoires TheaCompletedOcular Hypertension GlaucomaBulgaria
-
CHA UniversityHanlim Pharm. Co., Ltd.UnknownGlaucoma | Ocular HypertensiveKorea, Republic of
-
Western Galilee Hospital-NahariyaUnknown
-
The Eye Hospital of Wenzhou Medical UniversityRecruiting
-
Nanjing Medical UniversityUnknown
Clinical Trials on EasyEyeFM-AutoML-AI-platform test
-
Stanford UniversityUniversity of MichiganNot yet recruitingGenetic Predisposition | Family Members
-
Idoven 1903 S.L.Hospital General Universitario Gregorio Marañon; Spanish Society of CardiologyActive, not recruitingSTEMI - ST Elevation Myocardial InfarctionSpain
-
OpenGenomeRecruitingSkin Diseases | Myalgia | Fever | Signs and Symptoms | Hemorrhagic Fever With Renal Syndrome | ZoonosesGermany
-
Alexandria UniversityCompleted
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedCancerUnited States
-
Aiberry, IncTerminated
-
Nuvana Healthcare LTDNational Institute for Health Research, United KingdomRecruiting
-
Alexandria UniversityRecruitingRenal Insufficiency, Chronic | Stress, Psychological | Anxiety | Maintenance Hemodialysis | Relaxation TherapyEgypt
-
Shandong UniversityNot yet recruiting
-
BioFire Diagnostics, LLCUnknownRespiratory Tract Infections | Gastrointestinal InfectionUnited States